Philippe Grandjean

Dr. Philippe Grandjean


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in The Lancet Neurology
Verified
Journal Article
Closed access
PGPhilippe Grandjean
Philippe Grandjean
PLPhilip J. Landrigan
Philip J. Landrigan

1 December 2006 in The Lancet
Verified
Journal Article
Closed access
PGPhilippe Grandjean
Philippe Grandjean
PLPj Landrigan
Pj Landrigan

1 November 1997 in Neurotoxicology and Teratology
Verified
Journal Article
Open access
PGPhilippe Grandjean
Philippe Grandjean
PWPal Weihe
Pal Weihe
RWRoberta F White
Roberta F White
FDFrodi Debes
Frodi Debes
SAShunichi Araki
Shunichi Araki
PJPoul J Jørgensen
Poul J Jørgensen
A cohort of 1022 consecutive singleton births was generated during 1986-1987 in the Faroe Islands. Increased methylmercury exposure from maternal consumption of pilot whale meat was indicated by mercury concentrations in cord blood and maternal hair. At approximately 7 years of age, 917 of the children underwent detailed neurobehavioral examination. Neuropsychological tests included Finger Tapping; Hand-Eye Coordination; reaction time on a Continuous Performance Test; Wechsler Intelligence Scale for Children-Revised Digit Spans, Similarities, and Block Designs; Bender Visual Motor Gestalt Test; Boston Naming Test; and California Verbal Learning Test (Children). Clinical examination and neurophysiological testing did not reveal any clear-cut mercury-related abnormalities. However, mercury-related neuropsychological dysfunctions were most pronounced in the domains of language, attention, and memory, and to a lesser extent in visuospatial and motor functions. These associations remained after adjustment for covariates and after exclusion of children with maternal hair mercury concentrations above 10 microgram(s) (50 nmol/g). The effects on brain function associated with prenatal methylmercury exposure therefore appear widespread, and early dysfunction is detectable at exposure levels currently considered safe.

9 August 2016 in Environmental Science & Technology Letters
Verified
Journal Article
Open access
XHXindi C. Hu
Xindi C. Hu
DADavid Q. Andrews
David Q. Andrews
ALAndrew B. Lindstrom
Andrew B. Lindstrom
TBThomas A. Bruton
Thomas A. Bruton
LSLaurel A. Schaider
Laurel A. Schaider
Elsie M. SunderlandElsie M. Sunderland
Elsie M. Sunderland
Drinking water contamination with poly- and perfluoroalkyl substances (PFASs) poses risks to the developmental, immune, metabolic, and endocrine health of consumers. We present a spatial analysis of 2013–2015 national drinking water PFAS concentrations from the U.S. Environmental Protection Agency’s (US EPA) third Unregulated Contaminant Monitoring Rule (UCMR3) program. The number of industrial sites that manufacture or use these compounds, the number of military fire training areas, and the number of wastewater treatment plants are all significant predictors of PFAS detection frequencies and concentrations in public water supplies. Among samples with detectable PFAS levels, each additional military site within a watershed’s eight-digit hydrologic unit is associated with a 20% increase in PFHxS, a 10% increase in both PFHpA and PFOA, and a 35% increase in PFOS. The number of civilian airports with personnel trained in the use of aqueous film-forming foams is significantly associated with the detection of PFASs above the minimal reporting level. We find drinking water supplies for 6 million U.S. residents exceed US EPA’s lifetime health advisory (70 ng/L) for PFOS and PFOA. Lower analytical reporting limits and additional sampling of smaller utilities serving <10000 individuals and private wells would greatly assist in further identifying PFAS contamination sources.

25 January 2012 in JAMA
Verified
Journal Article
Open access
PDF file
PGPhilippe Grandjean
Philippe Grandjean
EAElisabeth Wreford Andersen
Elisabeth Wreford Andersen
EBEsben Budtz-Jørgensen
Esben Budtz-Jørgensen
FNFlemming Nielsen
Flemming Nielsen
KMKåre Mølbak
Kåre Mølbak
CHCarsten Heilmann
Carsten Heilmann
Fluorine-substituted organic compounds have thousands of important industrial and manufacturing applications and occur widely in surfactants and repellants in food packaging and textile impregnation.1 The perfluorinated compounds (PFCs) are highly persistent and cause contamination of drinking water, food, and food chains.1 The most common PFCs, perfluorooctanoic acid (PFOA, sometimes called C8), perfluorooctane sulfonic acid (PFOS), and perfluorohexane sulfonic acid (PFHxS), have elimination half-lives in humans of at least 4 years2 and are commonly detected in human serum.3

20 June 2012 in Environmental Health
Verified
Journal Article
Open access
PDF file
RBRobert Barouki
Robert Barouki
PGPeter D Gluckman
Peter D Gluckman
PGPhilippe Grandjean
Philippe Grandjean
MHMark Hanson
Mark Hanson
JHJerrold J Heindel
Jerrold J Heindel
This White Paper highlights the developmental period as a plastic phase, which allows the organism to adapt to changes in the environment to maintain or improve reproductive capability in part through sustained health. Plasticity is more prominent prenatally and during early postnatal life, i.e., during the time of cell differentiation and specific tissue formation. These developmental periods are highly sensitive to environmental factors, such as nutrients, environmental chemicals, drugs, infections and other stressors. Nutrient and toxicant effects share many of the same characteristics and reflect two sides of the same coin. In both cases, alterations in physiological functions can be induced and may lead to the development of non-communicable conditions. Many of the major diseases – and dysfunctions – that have increased substantially in prevalence over the last 40 years seem to be related in part to developmental factors associated with either nutritional imbalance or exposures to environmental chemicals. The Developmental Origins of Health and Disease (DOHaD) concept provides significant insight into new strategies for research and disease prevention and is sufficiently robust and repeatable across species, including humans, to require a policy and public health response. This White Paper therefore concludes that, as early development (in utero and during the first years of postnatal life) is particularly sensitive to developmental disruption by nutritional factors or environmental chemical exposures, with potentially adverse consequences for health later in life, both research and disease prevention strategies should focus more on these vulnerable life stages.